HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The effect of leukotriene-B4 receptor antagonist, SC-41930, on acetic acid-induced colonic inflammation.

Abstract
SC-41930, 7-[3-(4-acetyl-3-methoxy-2-propylphenoxy)-propoxy]-3,4-dihydro-8-p ropyl- 2H-1-benzopyran-2-carboxylic acid, is a potent in vitro leukotriene-B4 (LTB4) receptor antagonist. LTB4 levels are elevated in colonic tissue of inflammatory bowel disease (IBD) patients which may account for the high degree of neutrophil (PMN) infiltration. The guinea pig acetic acid-induced colonic inflammation model has characteristics of IBD including PMN infiltration, edema, ulceration and necrosis. The model was used to evaluate the effect of SC-41930. SC-41930 was given orally, 30 min before and after intrarectal administration of 3% acetic acid. The PMN marker enzyme, myeloperoxidase, was measured along with histological evaluation to assess inflammation. Both parameters showed significantly less inflammation in SC-41930 treated animals with an oral ED50 of 20 mg/kg. These study results with an LTB4 receptor antagonist indicate a role for LTB4 in colonic inflammation and that an LTB4 receptor antagonist may be beneficial for treatment of IBD.
AuthorsD J Fretland, S Levin, B S Tsai, S W Djurić, D L Widomski, J M Zemaitis, R L Shone, R F Bauer
JournalAgents and actions (Agents Actions) Vol. 27 Issue 3-4 Pg. 395-7 (Jun 1989) ISSN: 0065-4299 [Print] Switzerland
PMID2552769 (Publication Type: Journal Article)
Chemical References
  • Acetates
  • Benzopyrans
  • Receptors, Immunologic
  • Receptors, Leukotriene B4
  • SC 41930
  • Peroxidase
Topics
  • Acetates
  • Animals
  • Benzopyrans (pharmacology)
  • Colitis (chemically induced, enzymology, physiopathology)
  • Guinea Pigs
  • Male
  • Neutrophils (drug effects)
  • Peroxidase (metabolism)
  • Receptors, Immunologic
  • Receptors, Leukotriene B4

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: